Insider Sell: Sophie Vandebroek Sells Shares of IDEXX Laboratories Inc (IDXX)

Author's Avatar
Nov 30, 2024
Article's Main Image

On November 27, 2024, Sophie Vandebroek, Director at IDEXX Laboratories Inc (IDXX, Financial), sold 344 shares of the company. Following this transaction, the insider now owns 905 shares of IDEXX Laboratories Inc. The details of this transaction can be found in the SEC Filing. IDEXX Laboratories Inc is a company that specializes in the development, manufacture, and distribution of products and services for the veterinary, livestock, poultry, dairy, and water testing markets. The company is known for its innovative diagnostic and information technology-based products and services. Over the past year, Sophie Vandebroek has sold a total of 1,748 shares and has not purchased any shares. The insider transaction history for IDEXX Laboratories Inc shows that there have been 0 insider buys and 10 insider sells over the past year.

1862648519677079552.png

On the day of the recent sale, shares of IDEXX Laboratories Inc were trading at $420.44, giving the stock a market cap of $34.534 billion. The company's price-earnings ratio is 40.67, which is higher than the industry median of 29.51 but lower than the company’s historical median price-earnings ratio. With a price of $420.44 and a GF Value of $531.57, IDEXX Laboratories Inc has a price-to-GF-Value ratio of 0.79, indicating that the stock is modestly undervalued based on its GF Value.

1862648533291790336.png

The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. It also considers a GuruFocus adjustment factor based on the company’s past returns and growth, as well as future estimates of business performance from Morningstar analysts.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.